{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:15:43Z","timestamp":1791674143653,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.nbd.2020.104958","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T11:44:20Z","timestamp":1591616660000},"page":"104958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Why Woody got the blues: The neurobiology of depression in Huntington's disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Carolina","family":"Gubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-8922","authenticated-orcid":false,"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104958_bb0005","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/hmg\/ddv023","article-title":"A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits","volume":"24","author":"Aharony","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2020.104958_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107691","article-title":"Effects of deletion of mutant Huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease","volume":"9","author":"Baldo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104958_bb0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neubiorev.2016.09.006","article-title":"Neuroendocrine and neurotrophic signaling in Huntington\u2019s disease: implications for pathogenic mechanisms and treatment strategies","volume":"71","author":"Bartlett","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2020.104958_bb0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41374-018-0166-9","article-title":"Spectrum of tau pathologies in Huntington\u2019s disease","volume":"99","author":"Baskota","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.nbd.2020.104958_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2020.104958_bb0035","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.5110-12.2013","article-title":"Huntingtin mediates anxiety\/depression-related behaviors and hippocampal neurogenesis","volume":"33","author":"Ben M\u2019Barek","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-1781(01)00257-8","article-title":"Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington\u2019s disease gene carriers","volume":"102","author":"Berrios","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.nbd.2020.104958_bb0045","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"15","author":"Bj\u00f6rkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.neuropsych.13070169","article-title":"Reliability and factor structure of the short problem behaviors assessment for Huntington\u2019s disease (PBA-s) in the TRACK-HD and REGISTRY studies","volume":"27","author":"Callaghan","year":"2015","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2967\/jnumed.118.210393","article-title":"Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB 1 R levels","volume":"60","author":"Ceccarini","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2020.104958_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13311-012-0118-9","article-title":"Animal models of neurological disorders","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2020.104958_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2015.05.010","article-title":"Progression of behavioural despair in R6\/2 and Hdh knock-in mouse models recapitulates depression in Huntington\u2019s disease","volume":"291","author":"Ciamei","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2020.104958_bb0070","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JHD-180339","article-title":"Clinical presentation and features of juvenile-onset Huntington\u2019s disease: a systematic review","volume":"8","author":"Cronin","year":"2019","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2020.104958_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002944","article-title":"Clinical manifestations of intermediate allele carriers in Huntington disease","author":"Cubo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104958_bb0090","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1007\/s12035-018-0890-6","article-title":"Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington\u2019s disease mice","volume":"55","author":"da Fons\u00eaca","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104958_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05336-7","article-title":"Polyglutamine expansion affects huntingtin conformation in multiple Huntington\u2019s disease models","volume":"7","author":"Daldin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104958_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2015.11.003","article-title":"Disease stage, but not sex, predicts depression and psychological distress in Huntington\u2019s disease: a European population study","volume":"80","author":"Dale","year":"2016","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.nbd.2020.104958_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4056383","article-title":"Antidepressant effects of probucol on early-symptomatic YAC128 transgenic mice for Huntington\u2019s disease","volume":"2018","author":"de Paula Nascimento-Castro","year":"2018","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.nbd.2020.104958_bb0110","series-title":"The Psychiatric Phenotype in Huntington\u2019s Disease","author":"de Souza","year":"2015"},{"key":"10.1016\/j.nbd.2020.104958_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.4408","article-title":"Natural history of Huntington disease","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00032","article-title":"Is dysregulation of the HPA-Axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?","volume":"6","author":"Du","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0125","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/tp.2012.58","article-title":"Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington\u2019s disease","volume":"2","author":"Du","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2013.00081","article-title":"A tale of two maladies? Pathogenesis of depression with and without the Huntington\u2019s disease gene mutation","volume":"4","author":"Du","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2014.09.009","article-title":"The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington\u2019s disease","volume":"263","author":"Du","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the Predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104958_bb0150","series-title":"Anatomy and physiology of the hypothalamic-pituitary-gonadal (HPG) axis","first-page":"839","author":"Dwyer","year":"2019"},{"key":"10.1016\/j.nbd.2020.104958_bb0155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S2215-0366(16)30144-4","article-title":"Changes in mental state and behaviour in Huntington\u2019s disease","volume":"3","author":"Eddy","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0160","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jpsychires.2013.05.026","article-title":"Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study","volume":"47","author":"Epping","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.nbd.2020.104958_bb0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington\u2019s disease: a decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.nbd.2020.104958_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2016.01.019","article-title":"Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease","volume":"278","author":"Garcia-Miralles","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95665","article-title":"Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice","volume":"2","author":"Garcia-Miralles","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.nbd.2020.104958_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-017-0042-1","article-title":"Huntingtin gene repeat size variations affect risk of lifetime depression","volume":"7","author":"Gardiner","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104958_bb0190","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/1039856218791036","article-title":"Huntington\u2019s disease: neuropsychiatric manifestations of Huntington\u2019s disease","volume":"26","author":"Goh","year":"2018","journal-title":"Austr. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb3000","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00335","article-title":"Evaluation of biochemical and epigenetic measures of peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in Huntington\u2019s disease patients","volume":"12","author":"Gutierrez","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg.2017.115","article-title":"Tandem repeats mediating genetic plasticity in health and disease","volume":"19","author":"Hannan","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-018-0539-y","article-title":"Synaptopathy, circuitopathy and the computational biology of Huntington\u2019s disease","volume":"16","author":"Hannan","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.nbd.2020.104958_bb0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2826.2011.02238.x","article-title":"Deficits in spermatogenesis but not neurogenesis are alleviated by chronic testosterone therapy in R6\/1 Huntington\u2019s disease mice: testosterone as a chronic therapy for Huntington\u2019s disease","volume":"24","author":"Hannan","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.nbd.2020.104958_bb0215","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","article-title":"The limbic-hypothalamic-pituitary-adrenal axis in Huntington\u2019s disease","volume":"30","author":"Heuser","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0220","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1212\/WNL.0b013e3182984b31","article-title":"Huntington disease: how many repeats does it take?","volume":"80","author":"Hogarth","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104958_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YIC.0b013e3283348018","article-title":"Combating depression in Huntington\u02bcs disease: effective antidepressive treatment with venlafaxine XR","volume":"25","author":"Holl","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2020.104958_bb0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jne.12255","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington\u2019s disease and its association with depressive symptoms and suicidality","volume":"27","author":"Hubers","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.nbd.2020.104958_bb0235","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0240","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"Med. Surg. Rep."},{"key":"10.1016\/j.nbd.2020.104958_bb0245","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.410360412","article-title":"Trinucleotide repeat length and rate of progression of Huntington\u2019s disease","volume":"36","author":"Illarioshkin","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0250","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1134\/S0006297918090043","article-title":"Molecular pathogenesis in Huntington\u2019s disease","volume":"83","author":"Illarioshkin","year":"2018","journal-title":"Biochem. Mosc."},{"issue":"1","key":"10.1016\/j.nbd.2020.104958_bb1000","doi-asserted-by":"crossref","first-page":"e000027","DOI":"10.1136\/bmjno-2019-000027","article-title":"Case report and literature review of Huntington disease with intermediate CAG expansion","volume":"2","author":"Jevtic","year":"2020","journal-title":"BMJ Neurology Open"},{"key":"10.1016\/j.nbd.2020.104958_bb0255","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","article-title":"Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS","volume":"80","author":"Killoran","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104958_bb0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1037\/neu0000199","article-title":"Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease","volume":"29","author":"Kim","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nbd.2020.104958_bb0265","first-page":"192","article-title":"Longitudinal personality changes among presymptomatic Huntington disease gene carriers","volume":"15","author":"Kirkwood","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb2000","doi-asserted-by":"crossref","first-page":"104268","DOI":"10.1016\/j.nbd.2018.09.001","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease","volume":"135","author":"Kong","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1503\/jpn.100067","article-title":"Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography","volume":"36","author":"Krogias","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneur.1988.00520320071018","article-title":"Cerebrospinal fluid correlates of depression in Huntington\u2019s disease","volume":"45","author":"Kurlan","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0280","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.nbd.2020.104958_bb0285","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mdc3.12388","article-title":"Data analytics from Enroll-HD, a global clinical research platform for Huntington\u2019s disease","volume":"4","author":"Landwehrmeyer","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.nbd.2020.104958_bb0290","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0022-510X(95)00114-H","article-title":"Serum dehydroepiandrosterone and cortisol measurements in Huntington\u2019s chorea","volume":"132","author":"Leblhuber","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2020.104958_bb0295","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington\u2019s disease","volume":"162","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104958_bb0300","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset","volume":"178","author":"Lee","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104958_bb0305","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1039856218766120","article-title":"Huntington\u2019s disease: managing neuropsychiatric symptoms in Huntington\u2019s disease","volume":"26","author":"Loi","year":"2018","journal-title":"Austr. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0310","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington\u2019s disease: relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0315","first-page":"199","article-title":"Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington\u2019s disease","volume":"28","author":"Markianos","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.nbd.2020.104958_bb0320","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.42.9.1791","article-title":"Paralimbic frontal lobe hypometabolism in depression associated with Huntington\u2019s disease","volume":"42","author":"Mayberg","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104958_bb0325","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/hbm.23527","article-title":"Structural and functional brain network correlates of depressive symptoms in premanifest Huntington\u2019s disease: depressive Symptoms in preHD","volume":"38","author":"McColgan","year":"2017","journal-title":"Human Brain Mapping"},{"key":"10.1016\/j.nbd.2020.104958_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2016.12.021","article-title":"Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice","volume":"116","author":"McGregor","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.104958_bb0335","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104958_bb0340","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","article-title":"Environmental factors as modulators of neurodegeneration: insights from gene\u2013environment interactions in Huntington\u2019s disease","volume":"52","author":"Mo","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2020.104958_bb0345","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2020.104958_bb0350","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.25980","article-title":"Systematic review of pharmacological treatments for depressive symptoms in Huntington\u2019s disease: treatment of depressive symptoms in HD","volume":"29","author":"Moulton","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104958_bb0355","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0360","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1038\/cddis.2013.276","article-title":"Mechanisms of RNA-induced toxicity in CAG repeat disorders","volume":"4","author":"Nalavade","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0365","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fpsyt.2019.00974","article-title":"Cortisol and major depressive disorder-translating findings from humans to animal models and Back","volume":"10","author":"Nandam","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198338","article-title":"Sexual behavior and testis morphology in the BACHD rat model","volume":"13","author":"Novati","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104958_bb0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2020.104958_bb0380","doi-asserted-by":"crossref","first-page":"hzv005","DOI":"10.1093\/biohorizons\/hzv005","article-title":"Does loss of the normal protein function contribute to the pathogenesis of Huntington\u2019s disease?","volume":"8","author":"Paine","year":"2015","journal-title":"Biosci. Horiz."},{"key":"10.1016\/j.nbd.2020.104958_bb0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","article-title":"Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in huntington\u2019s disease transgenic mice","volume":"141","author":"Pang","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.104958_bb0390","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/brainsci7060067","article-title":"Neuropsychiatric burden in Huntington\u2019s disease","volume":"7","author":"Paoli","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2020.104958_bb0400","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington\u2019s disease: GnRH loss in R6\/2 Huntington mice","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0405","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mds.25864","article-title":"The cognitive burden in Huntington\u2019s disease: pathology, phenotype, and mechanisms of compensation: the cognitive burden in Hd","volume":"29","author":"Papoutsi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104958_bb0410","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0415","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","article-title":"Neuropsychiatric aspects of Huntington\u2019s disease","volume":"71","author":"Paulsen","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0420","series-title":"Handbook of Clinical Neurology","first-page":"69","article-title":"Cognitive and behavioral changes in Huntington disease before diagnosis","author":"Paulsen","year":"2017"},{"key":"10.1016\/j.nbd.2020.104958_bb0425","series-title":"Handbook of Clinical Neurology","first-page":"179","article-title":"The psychopharmacology of Huntington disease","author":"Peters\u00e9n","year":"2019"},{"key":"10.1016\/j.nbd.2020.104958_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington\u2019s disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0435","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JHD-150154","article-title":"Functional brain correlates of neuropsychiatric symptoms in presymptomatic Huntington\u2019s disease: the IMAGE-HD study","volume":"4","author":"Poudel","year":"2015","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0440","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104958_bb0445","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000481172","article-title":"Huntington\u2019s disease: premotor phase","volume":"17","author":"Ramos","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0450","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psym.2011.12.010","article-title":"Psychiatric disorders in Huntington\u2019s disease: a 2-year follow-up study","volume":"53","author":"Reedeker","year":"2012","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nbd.2020.104958_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington\u2019s disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104958_bb0460","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JHD-120039","article-title":"Antidepressant-like effect of the norepinephrine-dopamine reuptake inhibitor bupropion in a mouse model of Huntington\u2019s disease with dopaminergic dysfunction","volume":"1","author":"Renoir","year":"2012","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0465","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive-like behaviour in Huntington\u2019s disease mice by chronic sertraline and exercise: antidepressants in Huntington\u2019s disease mice","volume":"165","author":"Renoir","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.104958_bb0470","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2012.239798","article-title":"Differential effects of early environmental enrichment on emotionality related behaviours in Huntington\u2019s disease transgenic mice: emotionality related behaviours in Huntington\u2019s disease","volume":"591","author":"Renoir","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2020.104958_bb0475","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.64.6.813","article-title":"Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients","volume":"64","author":"Riba\u00ef","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0480","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1101\/gad.1436506","article-title":"Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle","volume":"20","author":"Riley","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2020.104958_bb0485","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0490","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psychres.2011.09.005","article-title":"Patterns of serotonergic antidepressant usage in prodromal Huntington disease","volume":"196","author":"Rowe","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.nbd.2020.104958_bb0495","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","article-title":"Lessons from animal models of Huntington\u2019s disease","volume":"18","author":"Rubinsztein","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","article-title":"Huntington\u2019s disease: molecular basis of neurodegeneration","volume":"5","author":"Rubinsztein","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.nbd.2020.104958_bb0505","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","article-title":"Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects","volume":"23","author":"Saarelainen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0510","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","article-title":"Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses","volume":"232","author":"Sahlholm","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2020.104958_bb0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.104958_bb0520","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0525","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington\u2019s disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2020.104958_bb0530","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1037\/a0029218","article-title":"Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease","volume":"26","author":"Smith","year":"2012","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nbd.2020.104958_bb0535","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.14723","article-title":"Alterations in synaptic function and plasticity in Huntington disease","volume":"150","author":"Smith-Dijak","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104958_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/srep28322","article-title":"Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington\u2019s disease","volume":"6","author":"Soylu-Kucharz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104958_bb0545","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0550","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0555","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0560","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JHD-150160","article-title":"Neuropsychiatry and white matter microstructure in Huntington\u2019s disease","volume":"4","author":"The Track-HD Investigators","year":"2015","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.nbd.2020.104958_bb0565","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2020.104958_bb0570","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/mds.23108","article-title":"A retrospective study of the impact of lifestyle on age at onset of Huntington disease: lifestyle and age at onset of HD","volume":"25","author":"Trembath","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104958_bb0575","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pscychresns.2012.01.002","article-title":"Depressive symptoms in prodromal Huntington\u2019s disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex","volume":"203","author":"Unschuld","year":"2012","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.nbd.2020.104958_bb0580","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington\u2019s in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104958_bb0585","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainresbull.2010.08.006","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis functioning in Huntington\u2019s disease mutation carriers compared with mutation-negative first-degree controls","volume":"83","author":"van Duijn","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2020.104958_bb0590","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19960216)67:1<53::AID-AJMG9>3.0.CO;2-T","article-title":"Psychiatric symptoms and CAG expansion in Huntington\u2019s disease","volume":"67","author":"Weigell-Weber","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0600","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","article-title":"Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS","volume":"52","author":"Willner","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.nbd.2020.104958_bb0605","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington\u2019s disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104958_bb0610","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw144","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104958_bb0615","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104958_bb0620","article-title":"Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington\u2019s disease mice","author":"Zajac","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.nbd.2020.104958_bb0625","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archneur.1996.00550060035012","article-title":"Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington\u2019s disease","volume":"53","author":"Zappacosta","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.104958_bb0630","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of Huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:08Z","timestamp":1760851268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120302333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":129,"alternative-id":["S0969996120302333"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104958","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why Woody got the blues: The neurobiology of depression in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104958"}}